Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

by Armstrong, A., Bliss, J.M, Brunt, A.M, Bundred, N., Cameron, D.A, Cramer, A., Cutress, R.I, Dodwell, D., Emson, M.A, Evans, A., Hanby, A., Hartup, S.M, Horgan, K., McIntosh, S.A, Miller, S.E, Morden, J.P, Naik, J., Narayanan, S., Ooi, J., Porta, N., Rakha, E.A, Shaaban, A.M, Skene, A.I
Published 2022